Japan and China Collaborate on Fatigue Research at 21st Conference

Japan and China Unite to Tackle Fatigue

The recent 21st Japanese Fatigue Society Conference, held at the Kobe International Conference Center from May 31 to June 1, 2025, marked a significant step in international collaboration on fatigue research. Jointly hosted by Alinamin Pharmaceuticals and the Japanese Fatigue Society, the seminar titled "New Developments in Japan-China Fatigue Research and the Potential of VB1 Derivative Fursultiamine" featured notable speakers including Dr. Yasuyoshi Watanabe, President of the Japanese Fatigue Society, and Dr. Yulong Cui, a prominent member of the Society and researcher in international cooperation with China.

During the seminar, attended by approximately 250 participants, the speakers discussed the advancements in fatigue research and presented the latest findings on Fursultiamine, an innovative anti-fatigue ingredient developed by Alinamin Pharmaceuticals. The response was overwhelmingly positive, highlighting the growing interest in tackling fatigue as a common health issue.

International Collaboration in Fatigue Research

The Japanese Fatigue Society has been a leading organization in fatigue research for over 20 years, not only hosting annual domestic conferences but also organizing international meetings on three occasions (in 2002, 2005, and 2008). Currently, they are fostering collaborations with prestigious Chinese institutions, such as Shantou University, Southern Medical University, Fudan University, and Beijing University of Chinese Medicine, with plans to establish an "International Fatigue Society" in the near future.

Exploring the Potential of Fursultiamine

In the presentations, significant insights were shared regarding Fursultiamine's impact on physical health. Researchers indicated that individuals who consistently consume Fursultiamine tend to exhibit higher levels of physical well-being, while lower blood vitamin B1 levels have been linked to cognitive decline. These findings underscore the importance of continued research on fatigue and health, with papers currently in preparation for publication.

A Shared Challenge Across Asia

Chronic fatigue affects over 70 million people in Japan alone. By population ratio, this suggests nearly 1 billion individuals in China might be facing similar challenges. This alarming statistic emphasizes the need for collaborative research and solutions tailored to address fatigue across Asian populations.

With the corporate message "Transforming Tomorrow's Vitality," Alinamin Pharmaceuticals is dedicated to enhancing health in various Asian countries. In China, they have received approval for the manufacture and marketing of Alinamin products as medical pharmaceuticals. The company is committed to supporting research initiatives related to vitality, sharing the latest data at conferences and fostering a vibrant, healthy life for as many individuals as possible.

Meet Dr. Yasuyoshi Watanabe

Dr. Yasuyoshi Watanabe, a key figure in fatigue research, serves as a special professor at Kobe University and is the CEO of Integrated Health Science. With a career spanning over three decades, he has significantly contributed to the understanding of fatigue mechanisms and the research of anti-fatigue substances. He established the Japanese Fatigue Society in 2005 and founded Integrated Health Science in 2023, aiming to maximize individual health through innovative assessment technologies.

For more information, you can visit the following links:

This conference represents a critical moment in fatigue research, fostering collaboration and innovation that could benefit millions across Asia as we continue to explore the depths of fatigue and its implications on health.